Sign in

Janux Therapeutics, Inc.

Income Statement - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.08 0.04 0.00 0.00
Gross profit 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total operating expenses + 0.17 0.11 0.08 0.08 0.04 0.00 0.00
Operating income -0.16 -0.10 -0.07 -0.07 -0.03 0.00 0.00
Non-operating income (net) 0.04 0.03 0.01 0.00 0.00 0.00 0.00
Income before tax -0.11 -0.07 -0.06 -0.06 -0.03 -0.01 0.00
Income tax expense 0.00 -0.01 0.00 0.00 0.00
Net income -0.11 -0.07 -0.06 -0.05 -0.03 -0.01 0.00
Show Quarterly Income Statement

Income Statement - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.01 0.01 0.00 0.00 -0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.01 0.00 0.00 -0.01 0.00 0.01 0.00 0.00 0.00 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.04 0.04 0.05 0.03 0.03 0.04 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating income -0.03 -0.04 -0.04 -0.05 -0.03 -0.03 -0.04 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.03 -0.02 -0.03 -0.02 -0.02 -0.03 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.02 -0.03 -0.02 -0.03 -0.02 -0.02 -0.03 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
4 days ago

Balance Sheet - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.97 1.03 0.34 0.33 0.37 0.01 0.00
Accounts receivable, net 0.01 0.01 0.00 0.00 0.00 0.01 0.00
Inventories 0.00 0.00 0.00
Other current assets 0.00 0.00 0.01 0.01 0.00 0.00
Total current assets 0.98 1.03 0.35 0.33 0.38 0.02 0.00
Total non-current assets + 0.03 0.03 0.03 0.03 0.00 0.00 0.00
Total assets 1.01 1.06 0.38 0.36 0.38 0.02 0.00
Total current liabilities + 0.02 0.02 0.01 0.02 0.01 0.00 0.00
Total non-current liabilities + 0.03 0.02 0.02 0.03 0.00 0.03 0.00
Total liabilities 0.05 0.04 0.04 0.04 0.01 0.03 0.01
Total stockholders' equity + 0.96 1.02 0.34 0.32 0.37 -0.01 -0.01
Common shares outstanding 62 54 44 41 41 42 42
Show Quarterly Balance Sheet

Balance Sheet - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.96 0.97 0.99 1.00 1.01 1.03 0.66 0.65 0.65 0.34 0.35 0.30 0.32 0.33 0.34 0.35 0.36 0.37 0.39 0.39 0.07 0.01 0.00 0.00 0.00
Accounts receivable, net 0.04 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 1.00 0.98 1.00 1.01 1.02 1.03 0.67 0.66 0.66 0.35 0.36 0.31 0.32 0.33 0.34 0.36 0.36 0.38 0.39 0.40 0.07 0.02 0.00
Total non-current assets + 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 1.03 1.01 1.02 1.03 1.05 1.06 0.70 0.69 0.69 0.38 0.39 0.34 0.35 0.36 0.38 0.39 0.37 0.38 0.39 0.40 0.07 0.02
Total current liabilities + 0.06 0.02 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Total non-current liabilities + 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.01 0.00 0.00 0.00 0.08 0.03
Total liabilities 0.09 0.05 0.05 0.04 0.04 0.04 0.04 0.03 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.01 0.01 0.01 0.01 0.09 0.03
Total stockholders' equity + 0.94 0.96 0.98 0.99 1.01 1.02 0.66 0.66 0.66 0.34 0.35 0.30 0.31 0.32 0.33 0.34 0.36 0.37 0.38 0.38 -0.02 -0.01 0.00
Common shares outstanding 63 62 62 62 62 57 55 54 49 47 46 42 42 42 42 41 41 41 41 10 40 12 12 12 12
4 days ago

Cash Flow - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.08 -0.04 -0.05 -0.04 -0.02 0.00 0.00
Cash flow from investing + -0.30 -0.26 -0.04 0.06 -0.34 -0.34 -0.34
Cash flow from financing + 0.00 0.71 0.06 0.00 0.39 0.01 0.00
Change in cash -0.38 0.41 -0.03 0.02 0.03 -0.33 -0.34
Show Quarterly Cash Flow

Cash Flow - Janux Therapeutics, Inc. (JANX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.01 -0.03 -0.01 -0.02 -0.02 -0.02 0.00 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.01 0.00 0.00 0.00 0.00
Cash flow from investing + 0.01 0.03 0.01 0.00 -0.34 0.03 0.01 -0.19 -0.11 0.01 -0.06 0.02 -0.01 0.00 0.02 0.01 0.03 0.01 -0.21 -0.14 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.32 0.00 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.33 0.06 0.00 0.00 0.01 0.00
Change in cash 0.00 0.00 0.00 -0.02 -0.36 0.40 0.01 -0.20 0.19 0.00 -0.02 0.00 -0.02 -0.01 0.01 0.00 0.02 0.00 -0.21 0.18 0.06 0.00 0.00 0.00 0.00
4 days ago

Janux Therapeutics, Inc. (JANX) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Change In Inventory

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Net Income

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Stock Based Compensation

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Cashflow From Investment

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

Janux Therapeutics, Inc. (JANX) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago